CRC Research Update — August 07, 2026
Today's colorectal cancer research highlights
Curated CRC research — accessible, accurate, actionable
The CRC Digest
Friday, August 07, 2026
IMPORTANT: The CRC Digest curates and summarizes publicly available research for informational and educational purposes only. Nothing in this newsletter constitutes medical advice, diagnosis, or treatment recommendation. The information provided should not be used as a substitute for professional medical advice. Always seek the guidance of your physician or other qualified health provider with any questions regarding a medical condition or treatment. Content is generated with AI assistance and reviewed by the editorial team. We are not medical professionals. Individual results, treatments, and outcomes vary.
CRC Research Update
-
TRIAL DATA
COMMIT Trial Evaluates Chemoimmunotherapy in dMMR Metastatic Colorectal CancerA new analysis examines what the COMMIT trial can and cannot tell us about combining chemotherapy with immunotherapy in patients with deficient DNA mismatch repair (dMMR) metastatic colorectal cancer. (Journal of Clinical Oncology)
-
RESEARCH
ALK Fusions Identified as Rare but Targetable Drivers in Colorectal CancerComprehensive genomic profiling of 56,206 advanced colorectal tumors characterized the prevalence and therapeutic implications of ALK fusions, which are established targets in lung cancer but rare in CRC. (The Oncologist)
-
TREATMENT
Natural Orifice Specimen Extraction Shows Promise for Rectal Cancer SurgeryA multicenter study of 3,385 rectal cancer patients aimed to compare short-term recovery, 6-month functional outcomes, and long-term survival among natural orifice specimen extraction surgery, laparoscopic surgery, and open surgery. (Diseases of the Colon & Rectum)
-
LIVING WITH CRC
Dementia Linked to Lower Surgery Rates and Survival in Stage I-III Colorectal CancerAnalysis of the Indiana Cancer Registry found that patients with dementia and stage I-III colorectal cancer have increased mortality and receive less invasive evaluations and surgery, with surgery utilization mediating survival differences. (Journal of the American Geriatrics Society)
Research continues to refine our understanding of colorectal cancer biology and treatment approaches. Talk with your care team about how these findings may relate to your situation.
Get CRC research intelligence delivered weekly — free.
SubscribeCRC Digest
Not Medical Advice
The CRC Digest provides research summaries for informational and educational purposes only. This is not medical advice. Always consult your healthcare provider before making any decisions about your care.
Content is curated with AI assistance and reviewed by the editorial team.
Browse Past Issues · Read our full disclaimer · Manage subscription
Useful? Forward it to a colleague. Every topic in this briefing has a live research dossier — trajectory and evidence — at Signal Bureau.
Got this from a colleague? Subscribe here — we only ever add readers who sign themselves up.
Evolution Accelerator, Inc. (dba Evolution Labs) · 3941 Park Dr., Suite 20341, El Dorado Hills, CA 95762
You are receiving this because you subscribed to CRC Digest (self-serve signup)
Unsubscribe — honored promptly, no login required. · Privacy policy · Manage or delete your data